OTCM
SKHHY
Market cap6.43bUSD
Oct 08, Last price
12.96USD
1D
-0.23%
1Q
-12.40%
Name
Sonic Healthcare Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Sydney, Australia, in 1934, Sonic Healthcare Limited is a prominent international provider of extensive medical diagnostic services. The company caters to a wide array of clients, including individual medical practitioners, hospitals, community health organizations, and, by extension, their patients. Sonic Healthcare's core operations are divided into three main service categories: 1. Laboratory Medicine/Pathology: This segment offers a broad spectrum of diagnostic testing, encompassing biochemistry, cytopathology (cell analysis), genetic screening, haematology (blood analysis), histopathology (tissue examination), immunoserology (immune system testing), microbiology (infectious disease detection), molecular pathology, prenatal testing, and toxicology, alongside various supporting laboratory functions. 2. Radiology Services: The company provides advanced medical imaging, which includes magnetic resonance imaging (MRI), computed tomography (CT) scans, ultrasound, X-ray, mammography, nuclear medicine, PET CT scans, interventional procedures, and bone mineral densitometry for assessing bone density. 3. Primary Care Medical Services: Sonic Healthcare also delivers a range of general practice and community health solutions. These comprise general practitioner clinics, occupational health support, specialized clinics for skin cancer, after-hours GP services, IT solutions designed for general practices, and other community-based healthcare initiatives. With a substantial global presence, Sonic Healthcare Limited conducts its operations across Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and other international regions.
Related entities
Subsidiaries (4)
Sonic Healthcare Holding Company
Sonic Healthcare Services Pty Limited
SH Euro Finance PLC
The Doctors Laboratory Limited
Key people
Mark Compton
Non-Executive Independent Chairman of the Board · since 2015
Chief Financial Officer, Finance Director, Executive Director · since 2014
Jim Newcombe
Chief Executive Officer, Managing Director, Director · since 2025
Paul Alexander
Deputy Chief Financial Officer, Company Secretary · since 2013
Non-Executive Independent Director · since 2022
Suzanne Crowe
Non-Executive Independent Director · since 2020
Nicola Evans
Non-Executive Independent Director · since 2025
Katharine Giles
Independent Non-Executive Director · since 2022
Non-Executive Independent Director · since 2017
Non-Executive Independent Director · since 2010
IPO date
Sep 25, 1934
Employees
41,000
Domiciled in
AU
Incorporated in
AU
Headquarters & legal address
Level 22
Grosvenor Place
225 George Street
Sydney, NSW 2000
AU
Grosvenor Place
225 George Street
Sydney, NSW 2000
AU
Previous name
Gunnersen Nosworth Limited
Previous name
Gunnersen Nosworthy Proprietary Limited
Previous name
Sonic Technology Australia Limited
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||